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Abstract
Introduction Prediction of death and prolonged mechanical
ventilation is important in terms of projecting resource utilization
and in establishing protocols for clinical studies of acute lung
injury (ALI). We aimed to identify risk factors for a combined
end-point of death and/or prolonged ventilator dependence and
developed an ALI-specific prediction model.
Methods In this retrospective analysis of three multicenter
clinical studies, we identified predictors of death or ventilator
dependence from variables prospectively recorded during the
first three days of mechanical ventilation. After the prediction
model was derived in an international cohort of patients with ALI,
it was validated in two independent samples of patients enrolled
in a clinical trial involving 17 academic centers and a North
American population-based cohort.
Results A combined end-point of death and/or ventilator
dependence at 14 days or later occurred in 68% of patients in
the international cohort, 60% of patients in the clinical trial, and
59% of patients in the population-based cohort. In the derivation
cohort, a model based on age, oxygenation index on day 3, and
cardiovascular failure on day 3 predicted death and/or ventilator
dependence. The prediction model performed better in the
clinical trial validation cohort (area under the receiver operating
curve 0.81, 95% confidence interval 0.77 to 0.84) than in the
population-based validation cohort (0.71, 95% confidence
interval 0.65 to 0.76).
Conclusion A model based on age and cardiopulmonary
function three days after the intubation is able to predict,
moderately well, a combined end-point of death and/or
prolonged mechanical ventilation in patients with ALI.
Introduction
Although a significant number of patients with acute lung injury
(ALI) die or require prolonged mechanical ventilation, the tools
for predicting mortality and morbidity in this group of patients
are limited [1,2]. Parameters related to the degree of impair-
ment in pulmonary function and nonpulmonary organ failures
have been associated with increased mortality and prolonged
mechanical ventilation in patients with ALI, and in mechanically
ventilated patients in general [1-11]. Compared with values
collected on day 1, evolution of the disease and response to
treatment during the first three days of mechanical ventilation
provide valuable prognostic information [1,2,12].
The present study analyzed potential predictors of outcome
from mechanical ventilation in patients with ALI in three recent
prospective cohorts with the following specific aims: to iden-
tify risk factors for death and/or ventilator dependence; to
develop an ALI-specific prediction model; and to validate the
prediction model in independent samples from both popula-
tion-based and clinical trial databases, in order to determine
ALI = acute lung injury; APACHE = Acute Physiology and Chronic Health Evaluation; ARDS = acute respiratory distress syndrome; CI = confidence 
interval; FiO2 = fractional inspired oxygen; OR = odds ratio; PaCO2 = arterial carbon dioxide tension; PaO2 = arterial oxygen tension; PEEP = positive 
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the potential value of the model for clinical decision making
and clinical trial design in patients who are likely to die or
require prolonged mechanical ventilation.
Materials and methods
In this retrospective study, we used data from patients with ALI
enrolled in three recent prospective cohorts. The detailed pro-
tocols of these three studies, namely the Second International
Study of Mechanical Ventilation (VENTILA) [13], the ARDS-
net clinical trial (low tidal volume [14] and lisophylline [15]),
and the King County Lung Injury Project (KCLIP) [16], have
previously been reported. The studies were approved by local
ethics committees in each participating institution. ALI and
acute respiratory distress syndrome (ARDS) were defined
according to the American-European Consensus conference
[17] in all three cohorts.
Outcome measures
The main outcome of interest was the composite outcome of
death in hospital and/or ventilator dependence for more than
two weeks after intubation (less than 14 ventilator-free days).
There are a number of reasons why we selected the combined
end-point of death and/or ventilator dependence. First, spe-
cific intensive care unit interventions that may be applied at the
bedside or tested in a clinical trial may affect both survival and
the duration of mechanical ventilation. Second, during the first
few days of mechanical ventilation it may be difficult to discrim-
inate between patients who will die in the hospital and those
who require prolonged mechanical ventilation but ultimately
will survive hospitalization. Third, the fact that a significant pro-
portion of survivors of prolonged mechanical ventilation expe-
rience a long-term decrease in quality of life may be particularly
important in the informed consent process and end-of life dis-
cussions in patients with respiratory failure who are at high risk
for death or prolonged mechanical ventilation. Finally, analo-
gous to the concept of ventilator-free days, the combined end-
point may be a more sensitive outcome for the design of clini-
cal trials testing specific therapeutic interventions.
Patient groups
Derivation cohort
From the VENTILA study database, we identified patients with
ALI who were alive and mechanically ventilated through an
endotracheal tube for at least three days. Patients who died,
who underwent earlier tracheostomy, or who were noninva-
sively ventilated on or before day 3 after initial intubation were
excluded.
Validation cohorts
Patients with ALI enrolled into the two ARDS-net studies (clin-
ical trial sample) and KCLIP study (population-based sample),
who were alive and mechanically ventilated through an
endotracheal tube on day 3 after intubation, were identified.
Those who died or were ventilated noninvasively during the
first three days after initial intubation were excluded. Tracheos-
tomy data were not available in the validation cohorts.
Measures and parameters recorded
A number of variables, prospectively collected during the first
three days of mechanical ventilation, were abstracted from the
databases. Baseline characteristics abstracted included age,
sex, body mass index, severity of illness (Simplified Acute
Physiology Score [SAPS] II [18] and Sequential Organ Failure
Assessment [19]), and underlying ALI risk factors (pulmonary
and extrapulmonary). Respiratory variables included peak and
plateau airway pressures, positive end-expiratory pressure
(PEEP), arterial oxygen tension (PaO2)/fractional inspired oxy-
gen (FiO2) ratio, arterial carbon dioxide tension (PaCO2), oxy-
genation index [8], and minute volume needed to bring PaCO2
to 40 mmHg (VE40) [6]. The following measures of nonpulmo-
nary organ failures were also abstracted: serum creatinine
(kidney), serum bilirubin (liver), platelet count (hematologic var-
iable), Glasgow Coma Scale score (neurologic variable), and
(arterial hypotension or the use of vasopressors (cardiovascu-
lar variable).
Oxygenation index was calculated using the following formula:
mean airway pressure × FiO2/PaO2. Mean airway pressure
was calculated as (peak airway pressure + PEEP)/2. VE40
was calculated as (minute volume × PaCO2)/40. Cardiovas-
cular failure was defined as systolic blood pressure less than
90 mmHg or the use of vasopressors, defined as follows: > 5
μg/kg per min dopamine or any dose of norepinephrine
(noradrenaline), epinephrine (adrenalilne), vasopressin, or
phenylephrine.
Statistical analysis
Data are summarized as median (interquartile range) or as pro-
portions. Univariate logistic regression analysis and recursive
partitioning were used to identify variables associated with
increased risk for death or ventilator dependence in the deri-
vation cohort. Stepwise multiple logistic regression identified
combination of variables with the best predictive ability. Varia-
bles were included in the model if they were biologically plau-
sible and associated with the outcome of interest in univariate
analysis (P < 0.1 or odds ratio ≥ 2.0 for nominal variables, or
a median split of continuous variables). The final model was
selected by backward elimination of nonsignificant variables.
Hosmer-Lemeshow statistics [20] were used to determine the
calibration of the model in each sample. Receiver operating
characteristic curves were plotted and area under the curve
for the prediction model was compared with those of general
severity scores measured in each of the cohorts. Two cutoff
scores (one more sensitive for clinical trial design and one
more specific for clinical practice and estimating resource uti-
lization) were identified in the derivation cohort and were sub-
sequently validated, with calculation of positive and negative
likelihood ratios for both cut-off scores. Where appropriate,
odds ratios (ORs) and 95% confidence intervals (CIs) wereAvailable online http://ccforum.com/content/11/3/R53
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calculated. P < 0.05 was considered statistically significant.
SAS statistical software (SAS Institute, Cary, NS, USA) was
used in all data analyses.
Results
The primary outcome (death and/or ventilator dependence for
longer than 14 days) occurred in 68% of patients in the inter-
national derivation cohort (VENTILA), in 60% of patients in the
clinical trial validation cohort (ARDS-net), and in 59% of
patients in the population-based validation cohort (KCLIP; Fig-
ure 1). Hospital mortality was 58% in VENTILA, 36% in ARDS-
net, and 43% in KCLIP.
Table 1 shows the association of the predictor variables with
death and/or ventilator dependence using univariate analyses
in the derivation cohort. A simple logistic regression model
(0.03 × age + 0.07 × day 3 oxygenation index + day 3 cardi-
ovascular failure [1 if present, 0 if absent]) had moderate dis-
criminative power and was well calibrated (Table 2, Figure 2
and Additional file 1).
In the clinical trial validation cohort, the model predicted death
or ventilator dependence better than day 1 SAPS II and Acute
Physiology and Chronic Health Evaluation (APACHE) II scores
(P < 0.01; Figure 2). The discriminative power and calibration
were good (Table 2). In the population-based validation
cohort, the model was less well calibrated and performed sim-
ilar to day 1 SAPS II score (Table 2 and Figure 2).
Both more sensitive (>3.0) and more specific (>3.5) cutoff
scores for the model were identified in the derivation cohort
and subsequently validated in the two validation cohorts
(Table 3). Positive and negative likelihood ratios for different
cutoff points of the model and for day 3 values of oxygenation
index and PaO2/FiO2 ratio are presented in Table 3. Missing
data precluded calculation of oxygenation index in 16% of
patients in the derivation (VENTILA) cohort, 25% in the ARDS-
net cohort, and 35% in the KCLIP cohort, and these patients
were excluded from the analysis.
Discussion
In this retrospective study of three recent, large cohorts of
patients with ALI, we observed that two-thirds of patients who
were alive and invasively ventilated on day 3 after endotracheal
intubation reached the composite outcome of death and/or
ventilator dependence for more than two weeks. A simple
model derived from age and cardiopulmonary function three
days after intubation predicted death and/or ventilator
dependence quite well in patients who were cared for in aca-
demic centers and enrolled in one of the ARDS-net trials. The
model performance was acceptable, but not as strong when
applied to the US population based cohort.
Altered lung mechanics and abnormal gas exchange are hall-
marks of impaired lung function in ALI and are of prognostic
significance [3]. Most models for quantifying gas exchange in
a clinical setting consider the lungs as having three compart-
ments: a shunt compartment, a dead space compartment, and
normal lung. The size of the shunt compartment is commonly
estimated by the PaO2/FiO2 ratio, whereas that of the dead
space compartment scales with dead space ventilation (Vd/
Vt) [3] and VE40 [6]. Both parameters are exquisitely sensitive
to cardiac output and ventilator management. To adjust for the
latter and to account for abnormal respiratory mechanics, cli-
nicians at times derive an oxygenation index, which is defined
Figure 1
Outline of the study Outline of the study. Shown are (a) the derivation cohort, (b) validation 
cohort (clinical trial), (c) validation cohort (population based). ALI, acute 
lung injury; ARDS, acute respiratory distress syndrome.Critical Care    Vol 11 No 3    Gajic et al.
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Figure 2
Area under receiving operator curves: model versus day 1 SAPS II and day 3 SOFA scores Area under receiving operator curves: model versus day 1 SAPS II and day 3 SOFA scores. (a) International derivation cohort (VENTILA), (b) clinical 
trial validation cohort (ARDS-Net), and (c) population-based validation cohort (KCLIP). SAPS, Simplified Acute Physiology Score; SOFA, Sequential 
Organ Failure Assessment.
Table 1
Baseline and day 3 characteristics of patients in the derivation cohort
Characteristic Alive and not ventilator dependent 
by day 15
Dead, ventilator-dependent, or 
with tracheostomy by day 15
P
Age 53 (40 to 66) 63 (49 to 72) 0.004
Female sex (n [%]) 34 (46) 87 (34) 0.063
BMI (kg/m2) 27 (24 to 31) 26 (23 to 31) 0.138
SAPS II score 46 (37 to 58) 47 (35 to 59) 0.760
Sepsis (n [%]) 28 (38%) 99 (39%) 0.897
Extrapulmonary cause of ALI/
ARDS (n [%])
29 (27%) 45 (20%) 0.205
Day 3 PaCO2 (mmHg) 39 (33 to 44) 41 (36 to 47) 0.012
Day 3 PaO2/FiO2 174 (146 to 195) 153 (105 to 198) 0.013
Day 3 Vt (ml/kg PBW) 9.1 (7.2 to 10.6) 8.5 (7.1 to 10.4) 0.181
Day 3 Ppl (cmH2O) 23 (19 to 26) 26 (21 to 30) 0.012
Day 3 Ppk (cmH2O) 28 (26 to 32) 31 (27 to 38) 0.010
Day 3 PEEP (cmH2O) 5 (5 to 9) 8 (5 to 12) 0.003
Day 3 VE40 (ml/kg PBW/min) 142 (109 to 186) 162 (128 to 214) 0.006
Day 3 oxygenation index 10.4 (8.2 to 14.7) 13.9 (9.3 to 23.1) 0.001
Day 3 ΔPEEP (cmH2O)a 0 (-2 to 0) 0 (0 to 3) < 0.001
Day 3 SOFA score 9 (7 to 10) 10 (7 to 13) 0.055
Day 3 shock (n [%]) 14 (19) 99 (39) 0.001
The values are presented as median (interquartile range) for continuous variables and number (%) for categorical variables. ALI, acute lung injury/
acute respiratory distress syndrome; BMI, body mass index; FiO2, fractional inspired oxygen; PaCO2, arterial carbon dioxide tension; PaO2, arterial 
oxygen tension; PBW, predicted body weight; PEEP, positive end-expiratory pressure; Ppk, peak airway pressure; Ppl, plateau airway pressure; 
SAPS, Simplified Acute Physiology Score; SOFA, Sequential Organ Failure Assessment, VE40, minute ventilation required to achieve PaCO2 of 
40 mmHg; Vt, tidal volume. aPEEP at day 3 minus PEEP at day 1.Available online http://ccforum.com/content/11/3/R53
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as the PaO2/FiO2 ratio normalized by mean airway pressure.
Oxygenation index has been associated with outcome in both
adults and children with ALI [7,8]. Apart from oxygenation
index, other parameters relating to the ventilator (PEEP and
plateau pressure) or gas exchange (PaCO2 and VE40) did not
significantly contribute to the discriminative power of our
model.
The presence of persistent shock, renal failure, age, immuno-
suppression, underlying cause of ALI, and overall severity of ill-
ness were previously identified as important nonpulmonary
outcome determinants [1,2,4,5,10,21,22]. In the ARDS-net
low tidal volume study [14], age, APACHE II score, plateau
pressure, the number of organ failures (using the Brussels
Organ Failure Classification), number of hospital days before
enrollment, and arterial-alveolar oxygen gradient were found to
be independent prognostic factors, and were used in the
mortality adjustments reported in the recent ARDS-net study
[11]. Age by itself is known to be an important predictor of
Table 2
Performance of the prediction model
Study cohort Discriminationa Calibrationb
Derivation
VENTILA 0.72 (0.65 to 0.79) 0.78
Validation
ARDS-Net 0.81 (0.77–0.84) 0.12
KCLIP 0.71 (0.65–0.76) 0.03
aArea under the receiver operating curve (95% confidence interval). 
bHosmer-Lemeshow goodness of fit (P value).
Table 3
Positive and negative likelihood ratios for predicting death or more than 14 days of ventilator dependency
Patient population Diagnostic modality Statistic Estimate (95% CI)
VENTILA Model (≤ 3.0) LR+ 2.52 (1.57 to 4.07)
LR- 0.56 (0.46 to 0.69)
Model (≤ 3.5) LR+ 3.53 (1.72 to 7.24)
LR- 0.68 (0.59 to 0.79)
Oxygenation index (≤ 15) LR+ 1.98 (1.22 to 3.21)
LR- 0.72 (0.6 to 0.86)
PaO2/FiO2 (≤ 150) LR+ 1.77 (1.2 to 2.62)
LR- 0.70 (0.58 to 0.85)
ARDS-net Model (≤ 3) LR+ 3.15 (2.38 to 4.19)
LR- 0.40 (0.33 to 0.48)
Model (≤ 3.5) LR+ 6.86 (4.1 to 11.47)
LR- 0.51 (0.46 to 0.58)
Oxygenation index (≤ 15) LR+ 2.18 (1.71 to 2.77)
LR- 0.52 (0.44 to 0.62)
PaO2/FiO2 (≤ 150) LR+ 1.98 (1.6 to 2.45)
LR- 0.57 (0.49 to 0.66)
KCLIP Model (≤ 3) LR+ 1.56 (1.3 to 1.87)
LR- 0.45 (0.34 to 0.6)
Model (≤ 3.5) LR+ 1.83 (1.42 to 2.37)
LR- 0.58 (0.47 to 0.71)
Oxygenation index (≤ 15) LR+ 1.75 (1.33 to 2.32)
LR- 0.67 (0.56 to 0.8)
PaO2/FiO2 (≤ 150) LR+ 2.22 (1.69 to 2.92)
LR- 0.62 (0.54 to 0.72)
CI, confidence interval; FiO2, fractional inspired oxygen; LR+, positive likelihood ratios; LR-, negative likelihood ratios; PaO2, arterial oxygen 
tension.Critical Care    Vol 11 No 3    Gajic et al.
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poor outcome in patients with ALI [23]. Except for age and day
3 cardiovascular failure, additional markers of nonpulmonary
organ failures (creatinine, platelet count, bilirubin, and Glas-
gow Coma Scale score) did not contribute to the discrimina-
tive power of our model. A logistic model similar to ours and
based on age and day 3 oxygenation impairment was found to
be predictive of prolonged mechanical ventilation in burn
patients [24].
Of note, our model had better discrimination in a clinical trial
dataset than in the two observational cohorts. This suggests
that unmeasured factors related to co-interventions such as
ventilator management or weaning, end of life care, and co-
morbidities may introduce heterogeneity in patients who meet
ALI definition in observational studies. Nevertheless, the
model discrimination did not worsen when it was evaluated in
the real-world setting of a population-based cohort of patients.
One of the objectives of our prediction model was to aid in
decision making and clinical trial design with regard to the tim-
ing of tracheostomy. In a recent clinical trial conducted by
Rumbak and coworkers [25], patients randomly assigned to
early tracheostomy not only had shorter duration of mechani-
cal ventilation and intensive care unit length of stay but also
markedly lower hospital mortality (31.7% versus 61.7%; P <
0.005). Although the authors did not specifically address how
many of these patients met criteria for ALI, it is likely, based on
the description of the patient population, that a significant
number of patients did indeed have ALI. One of the main criti-
cisms of this study included somewhat arbitrary prediction of
the need for prolonged mechanical ventilation (APACHE II
score > 25). We believe that our model could be used in future
studies of early versus late tracheostomy in patients with ALI.
The principal limitations or our study stem from its retrospec-
tive design insofar as neither of the original studies were
designed to answer our questions. It is possible that some var-
iables that were not routinely collected, for example Vd/Vt or
net fluid balance, might have added to the model. Missing data
precluded calculation of the oxygen index and, therefore, of the
model for a significant number of patients. Having missing
data did not significantly influence the outcome in the deriva-
tion cohort (OR 1.12, 95% CI 0.56 to 2.41). In the validation
cohorts, missing data were associated with a lower risk for
death or prolonged ventilation (OR 0.55, 95% CI 0.39 to 0.78
in the ARDS-net sample; OR 0.64, 95% CI 0.45 to 0.90 in the
KCLIP sample). Although the design of our study does not
allow us to state the reasons for the missing data, we specu-
late that patients in whom the data needed to calculate oxy-
genation index were lacking (mean airway pressure and FiO2/
PaO2) may have been improving clinically and undergoing
weaning attempts.
Although our choice of a combined outcome including death
and prolonged mechanical ventilation as the primary outcome
may be questioned, it is important to emphasize that the two
may not be reliably differentiated during the first few days of
mechanical ventilation. The distinction between patients who
die and those who undergo prolonged mechanical ventilation
could be related to the preferences of patients and physicians
regarding withholding of prolonged ventilation and rehabilita-
tion, bearing in mind the potential poor quality of life in the
future that may result from such interventions. Among the
patients who survive the first few days of mechanical ventila-
tion, the mortality and prolonged mechanical ventilation may
be viewed as different ends of the spectrum of poor prognosis
in patients with ALI. Improvement in the accuracy of prediction
in future prospective studies will require careful consideration
not only of factors related to underling pulmonary and nonpul-
monary organ dysfunction but also of the characteristics of
individual practices, patient preferences, premorbid functional
status, and, possibly, biomarkers of lung injury and systemic
inflammation.
Conclusion
A majority of patients with ALI are at risk for death or prolonged
mechanical ventilation. A model derived from age, oxygenation
index, and cardiovascular failure three days after intubation
predicts death or prolonged mechanical ventilation and may
inform decisions regarding specific interventions such as tra-
cheostomy, particularly in terms of clinical trial design. How-
ever, because of the retrospective design of the present study,
a validation study is warranted in an independent sample of
patients.
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Key messages
￿  A substantial number of patients with ALI reached the 
combined end-point of death in the hospital or pro-
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￿  A simple model consisting of age and cardiopulmonary 
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death and/or prolonged mechanical ventilation in 
patients with ALI.
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